BSF Enterprise Plc (BSFA.L)

LSE Healthcare Biotechnology

BSF Enterprise Plc operates in the Biotechnology industry of the Healthcare sector, headquartered in London, GL, GB. The stock last traded at $1.10, down 4.26% on the session, giving a market capitalisation of $14,121. Its beta of 3.61 implies it has historically moved more than the broad market.

BSF Enterprise PLC is a United Kingdom-based biotech company. The Company develops and commercializes cell-based tissue engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The principal activity of the Company is to undertake the acquisition of businesses in the biotechnology, marketing and e-commerce sectors.

BSF Enterprise Plc is most often compared with the following Healthcare names: